Overview

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)

Status:
Completed
Trial end date:
2013-12-10
Target enrollment:
Participant gender:
Summary
A pilot evaluation of tenecteplase compared to alteplase in acute ischaemic stroke patients currently eligible for intravenous alteplase treatment in a prospective, randomised, blinded outcome evaluation clinical trial using brain imaging as a biomarker.
Phase:
Phase 2
Details
Lead Sponsor:
NHS Greater Glasgow and Clyde
Collaborator:
University of Glasgow
Treatments:
Plasminogen
Tenecteplase
Tissue Plasminogen Activator